Charles River Laboratories International Inc - Company Profile
Powered by
All the data and insights you need on Charles River Laboratories International Inc in one report.
- Save hours of research time and resources with
our up-to-date Charles River Laboratories International Inc Strategy Report
- Understand Charles River Laboratories International Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Charles River Laboratories International Inc (Charles River), is a contract research organization (CRO) that provides essential products and services to accelerate research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The company also offers clinical, manufacturing and operations and staffing support. It provides solutions focused on therapy areas related to cardiovascular, central nervous system, metabolic, inflammation, oncology, ophthalmology, respiratory, and musculoskeletal disorders. Charles River provides products and services to pharmaceutical and biotechnology companies, government agencies, besides leading hospitals and academic institutions. Charles River is headquartered in Wilmington, Massachusetts, the US.
Charles River Laboratories International Inc premium industry data and analytics
Products and Services
Services |
---|
Antibody Production Services |
Biopharmaceutical Services |
Avian Vaccine Services |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In April, the company signed a Good Manufacturing Practice plasmid DNA contract development and manufacturing organization agreement with Ship of Theseus to support Charles River’s premier expertise in manufacturing GMP plasmid DNA. |
2024 | New Products/Services | In April, the company launched the same-day delivery of fresh leukopaks to Cambridge, Greater Boston, and the San Diego biohub. |
2024 | New Products/Services | In April, the company introduced the Alternative Methods Advancement Project. |
Competitor Comparison
Key Parameters | Charles River Laboratories International Inc | Almac Group Ltd | BioReliance Corp | Corgenix Medical Corp | IMR Partner International Medical Research GmbH |
---|---|---|---|---|---|
Headquarters | United States of America | United Kingdom | United States of America | United States of America | Germany |
City | Wilmington | Craigavon | Rockville | Broomfield | Grafelfing |
State/Province | Massachusetts | Northern Ireland | Maryland | Colorado | Bayern |
No. of Employees | 20,000 | 6,600 | - | - | - |
Entity Type | Public | Private | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
James C. Foster | Chief Executive Officer; President; Chairman | Executive Board | 2000 | 72 |
Flavia H. Pease | Chief Financial Officer; Executive Vice President | Senior Management | 2022 | - |
Birgit Girshick | Corporate Executive Vice President; Chief Operating Officer | Senior Management | 2021 | 52 |
Michael G. Knell | Chief Accounting Officer; Senior Vice President | Senior Management | 2017 | - |
John C. Ho, M.D. | Chief Strategy Officer; Senior Vice President - Corporate Strategy | Senior Management | 2012 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer